These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11187883

  • 1. Factor VIII inhibitor with catalytic activity towards factor VIII.
    Lacroix-Desmazes S, Sooryanarayana, Moreau A, Kazatchkine MD, Kaveri SV.
    Haematologica; 2000 Oct; 85(10 Suppl):89-92. PubMed ID: 11187883
    [Abstract] [Full Text] [Related]

  • 2. Catalytic activity of antibodies against factor VIII in patients with hemophilia A.
    Lacroix-Desmazes S, Moreau A, Sooryanarayana, Bonnemain C, Stieltjes N, Pashov A, Sultan Y, Hoebeke J, Kazatchkine MD, Kaveri SV.
    Nat Med; 1999 Sep; 5(9):1044-7. PubMed ID: 10470082
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies to factor VIII with catalytic activity.
    Bayry J, Lacroix-Desmazes S, Pashov A, Stahl D, Hoebeke J, Kazatchkine MD, Kaveri SV.
    Autoimmun Rev; 2003 Jan; 2(1):30-5. PubMed ID: 12848973
    [Abstract] [Full Text] [Related]

  • 4. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA, Levin LG, Harrison JA, DePianto DJ, Suzuki CM, Ziaja CL, Brown JE, Jolly KW, Reisner HM, Abildgaard CF, Powell JS.
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of proteolytic antibodies against factor VIII in hemophilia A.
    Lacroix-Desmazes S, Bayry J, Misra N, Horn MP, Villard S, Pashov A, Stieltjes N, d'Oiron R, Saint-Remy JM, Hoebeke J, Kazatchkine MD, Reinbolt J, Mohanty D, Kaveri SV.
    N Engl J Med; 2002 Feb 28; 346(9):662-7. PubMed ID: 11870243
    [Abstract] [Full Text] [Related]

  • 6. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B, Mahendra A, Dimitrov JD, Friboulet A, Borel-Derlon A, Rao DN, Uda T, Borg JY, Bayry J, Kaveri SV, Lacroix-Desmazes S.
    FEBS Lett; 2009 Aug 06; 583(15):2565-72. PubMed ID: 19595998
    [Abstract] [Full Text] [Related]

  • 7. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S, Sharifian RA, Khoshnoodi J, Karimi K, Milani M, Okita DK, Shokri F, Conti-Fine BM.
    Thromb Haemost; 2009 May 06; 101(5):834-9. PubMed ID: 19404535
    [Abstract] [Full Text] [Related]

  • 8. Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia.
    Wootla B, Dasgupta S, Dimitrov JD, Bayry J, Lévesque H, Borg JY, Borel-Derlon A, Rao DN, Friboulet A, Kaveri SV, Lacroix-Desmazes S.
    J Immunol; 2008 Jun 01; 180(11):7714-20. PubMed ID: 18490775
    [Abstract] [Full Text] [Related]

  • 9. Factor VIII inhibitors: role of von Willebrand factor on the uptake of factor VIII by dendritic cells.
    Kaveri SV, Dasgupta S, Andre S, Navarrete AM, Repessé Y, Wootla B, Lacroix-Desmazes S.
    Haemophilia; 2007 Dec 01; 13 Suppl 5():61-4. PubMed ID: 18078399
    [Abstract] [Full Text] [Related]

  • 10. Hydrolysis of factor VIII mediated by catalytic antibodies occurs in haemophilia A patients with or without factor VIII inhibitors.
    Grosbois SS, Brionne MF, de Longcamp AL, Gautier P, V Kaveri S, Borel-Derlon A, Repessé Y.
    Haemophilia; 2013 Mar 01; 19(2):322-9. PubMed ID: 23216758
    [Abstract] [Full Text] [Related]

  • 11. Neutralizing antiidiotypic antibodies to factor VIII inhibitors after desensitization in patients with hemophilia A.
    Gilles JG, Desqueper B, Lenk H, Vermylen J, Saint-Remy JM.
    J Clin Invest; 1996 Mar 15; 97(6):1382-8. PubMed ID: 8617869
    [Abstract] [Full Text] [Related]

  • 12. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism.
    Nogami K, Shima M, Nishiya K, Sakurai Y, Tanaka I, Giddings JC, Saenko EL, Yoshioka A.
    Thromb Haemost; 2002 Mar 15; 87(3):459-65. PubMed ID: 11916079
    [Abstract] [Full Text] [Related]

  • 13. Immunobiology of inhibitor development in hemophilia A.
    Fijnvandraat K, Bril WS, Voorberg J.
    Semin Thromb Hemost; 2003 Feb 15; 29(1):61-8. PubMed ID: 12640567
    [Abstract] [Full Text] [Related]

  • 14. Anti-factor VIII antibodies: a 2005 update.
    Lavigne-Lissalde G, Schved JF, Granier C, Villard S.
    Thromb Haemost; 2005 Oct 15; 94(4):760-9. PubMed ID: 16270627
    [Abstract] [Full Text] [Related]

  • 15. Catalytic antibodies to factor VIII in haemophilia A.
    Lacroix-Desmazes S, Kazatchkine MD, Kaveri SV.
    Blood Coagul Fibrinolysis; 2003 Jun 15; 14 Suppl 1():S31-4. PubMed ID: 14567533
    [Abstract] [Full Text] [Related]

  • 16. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
    Johnson DJ, Pemberton S, Acquila M, Mori PG, Tuddenham EG, O'Brien DP.
    Thromb Haemost; 1994 Apr 15; 71(4):428-33. PubMed ID: 8052958
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM, van Helden PM, Schwarz HP, Hausl C.
    Br J Haematol; 2007 Jan 15; 136(1):12-25. PubMed ID: 17222196
    [Abstract] [Full Text] [Related]

  • 18. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM, Sasgary M, Ahmad RU, Auer W, Turecek PL, Schwarz HP.
    Thromb Haemost; 2001 Dec 15; 86(6):1345-52. PubMed ID: 11776297
    [Abstract] [Full Text] [Related]

  • 19. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains.
    Chaves DG, Velloso-Rodrigues C, Moreau V, Nguyen C, Villard S, Belisário AR, Granier C, Santoro MM.
    Br J Haematol; 2008 May 15; 141(5):708-15. PubMed ID: 18422780
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.